EXPERIMENTAL and MOLECULAR MEDICINE, EMM, publishes research papers and a limited number of reviews in the fields of basic and applied molecular biology, and experimental biochemistry in medicine. Research areas include analysis of gene structure, function and regulation; molecular mechanisms of genetic recombination; recombinant nucleic acid technology and gene therapy. EMM is also dedicated to the experimental biochemistry in medicine, including the regulatory mechanisms of body functions; structural biology and interaction between proteins and/or nucleic acids. Although special research areas are emphasized for publication, articles dealing with molecular biology and experimental biochemistry in other areas will also be welcomed.
Experimental Aging Research is a life span developmental and aging journal dealing with research on the aging process from a psychological and psychobiological perspective. It meets the need for a scholarly journal with refereed scientific papers dealing with age differences and age changes at any point in the adult life span. Areas of major focus include experimental psychology, neuropsychology, psychobiology, work research, ergonomics, and behavioral medicine. Original research, book reviews, monographs, and papers covering special topics are published. Peer Review Policy: All review papers in this journal have undergone editorial screening and peer review. Publication office: Taylor & Francis, Inc., 325 Chestnut Street, Suite 800, Philadelphia, PA 19106.
Experimental Biology and Medicine is a journal dedicated to the publication of multidisciplinary and interdisciplinary research in the biomedical sciences. Published monthly, EBM provides both research and review articles as well as meeting symposia and brief communications. Articles in EBM represent cutting edge research at the overlapping junctions of the biological, physical and engineering sciences that impact upon the health and welfare of the world's population. Topics covered in EBM include: Anatomy/Pathology; Biochemistry and Molecular Biology; Cell and Developmental Biology; Endocrinology and Nutrition; Immunology/Microbiology/Virology; Neuroscience; Pharmacology and Toxicology; Physiology; Bioimaging; Biomedical Engineering; Bionanoscience; Genomics, Proteomics, and Bioinformatics; Stem Cell Biology; Systems Biology, and Translational Research.
Experimental Cell Research promotes the understanding of cell biology by publishing experimental studies on the general organization and activity of cells. The scope of the journal includes all aspects of cell biology, from the molecular level to the level of cell interaction and differentiation.Experimental Cell Research publishes papers in the area of cell and molecular biology, and papers must provide novel and significant insights into important problems in these areas. Areas of interest include, but are not restricted to:- Apoptosis and programmed cell death- Cancer research- Cell cycle- Cell proliferation and differentiation- Cellular motility and migration- Cell-cell and cell-matrix interaction- Chromatin- Chromosome structure and dynamics- Cytoskeleton- Developmental biology- DNA repair- Epigenetics- Extracellular matrix- Gene regulation- Intracellular trafficking- Mammalian genetic models- Meiosis and mitosis- MicroRNA- Nuclear import-export- RNA processing- Signal transduction- Stem cell biology- Subcellular organizationExperimental Cell Research has partnered with Gastroenterologyhttp://www.gastrojournal.org/ to offer fast track review for certain articles. Articles rejected from Gastroenterology because of their strong biological focus may be directed to ECR for fast track review. Similarly, articles deemed too clinical for ECR and more appropriate for Gastroenterology may be fast tracked through Gastroenterology's review process. Both journals retain editorial independence and reserve the right to request additional changes, re-review, or reject manuscripts.
Experimental Dermatology provides a vehicle for the rapid publication of innovative and definitive reports, letters to the editor and review articles covering all aspects of experimental dermatology. Preference is given to papers of immediate importance to other investigators, either by virtue of their new methodology, experimental data or new ideas. The essential criteria for publication are clarity, experimental soundness and novelty. Letters to the editor related to published reports may also be accepted, provided that they are short and scientifically relevant to the reports mentioned, in order to provide a continuing forum for discussion. Review articles represent a state-of-the-art overview and are invited by the editors. Colour illustrations will be accepted free of charge.
The primary goal of Experimental Eye Research is to publish original research papers on all aspects of experimental biology of the eye and ocular tissues that seek to define the mechanisms of normal function and/or disease. Studies of ocular tissues that encompass the disciplines of cell biology, developmental biology, genetics, molecular biology, physiology, biochemistry, biophysics, immunology or microbiology are most welcomed. Manuscripts that are purely clinical or in a surgical area of ophthalmology are not appropriate for submission to Experimental Eye Research and if received will be returned without review.Most manuscripts published are original articles describing new research findings. For review purposes the journal is divided into four sections: Aqueous Humor and Blood Flow; Cornea and Ocular Surface; Lens; and Retina and Choroid, each with their own section editors and a roster of Executive Editors that have expertise in these specialized areas.The Journal also publishes review articles, short communications, letters-to-the-editor, and methods papers. Full descriptions of each of these types of articles are detailed in the Guide for Authors.Research areas include:Production and circulation of ocular fluids and the dysfunction of these pathways underlying ocular diseaseAngiogenesis, neovascularization and regulation of blood flow in the eye in health and diseaseCell biology, molecular biology, biochemistry, and biophysics of the eye or eye tissueDevelopmental and regenerative biology of the eyeHuman and molecular genetics studies of inherited eye diseasesGene therapy and neuroprotection targeted at preventing inherited ocular diseasesNeural and general physiology of the visual process
Experimental Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology with emphasis on preclinical, basic, patient-oriented and translational research. The journal acts as an international platform for sharing laboratory findings in these areas and makes a deliberate effort to publish clinical trials with 'negative' results and basic science studies with provocative findings.Experimental Hematology & Oncology aims to publish original work, hypothesis, commentaries and timely reviews in the closely related fields of hematology and oncology.With open access, rapid turnaround time from submission to publication and online live comments from readers, Experimental Hematology & Oncology will strive to be the hub for disseminating new knowledge and discussing controversial topics for both basic scientists and busy clinicians in the field of hematology and oncology.
Initial review of manuscripts averages under 4 weeksArticles published online from 5 days after acceptanceUnrivalled access to 10 million healthcare professionals through ScienceDirectOver 280,000 article downloads in 2012Impact factor of 2.905 (© Thomson Reuters Journal Citation Reports 2012)Experimental Hematology publishes original research reports (regular and fast-track submissions), reviews, perspectives, letters to the editor, and abstracts of the annual meeting of ISEH - Society for Hematology and Stem Cells. We welcome manuscripts describing basic in vitro and in vivo research centered on normal and malignant hematopoiesis as well as non-malignant hematologic diseases. Submissions focused on non-hematopoietic stem cells (e.g. mesenchymal stem cells, embryonic stem cells and induced pluripotent stems) with potential relevance to hematopoiesis are also welcome, as are studies involving experimental or early phase clinical cell transplantation. Studies employing genomic and systems biology approaches to the study of normal and malignant hematopoiesis are strongly encouraged, as are those employing model organisms.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Experimental Parasitology emphasizes modern approaches to parasitology, including molecular biology and immunology. The journal features original research papers on the physiological, metabolic, immunologic, biochemical, nutritional, and chemotherapeutic aspects of parasites and host-parasite relationships.Most downloaded papersBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Experimental and Applied Acarology publishes peer-reviewed original papers describing advances in basic and applied research on mites and ticks. Coverage encompasses all Acari, including those of environmental, agricultural, medical and veterinary importance, and all the ways in which they interact with other organisms (plants, arthropods and other animals). The subject matter draws upon a wide variety of disciplines, including evolutionary biology, ecology, epidemiology, physiology, biochemistry, toxicology, immunology, genetics, molecular biology and pest management sciences.Experimental and Applied Acarology is edited by Maurice W. Sabelis, Jan Bruin and Frans Jongejan.
5-Year Impact Factor: 1.449Experimental and Clinical Endocrinology & Diabetes publishes outstanding articles from all fields of endocrinology and diabetology. From molecular biology to clinical research, the journal covers all aspects of these fields. Original contributions and commentaries appear in each issue along with reviews addressing current topics.
Experimental and Clinical Psychopharmacology publishes advances in translational and interdisciplinary research on psychopharmacology and drug abuse. The scope of research in these areas continues to expand and to benefit from collaborations across a broad range of disciplines, including behavioral science, brain imaging, genetics, neuroendocrinology, neuroscience, and pharmacology.One goal of the journal is to encourage increased attention to biologic factors that may influence both the pharmacodynamic and the pharmacokinetic effects of drugs. Recent research has shown the importance of examining the effects of sex and menstrual/estrous cycle phase on the effects of abused drugs, as well as responses to medications for the treatment of drug abuse and the alleviation of pain.The journal publishes original reports on the development and evaluation of new pharmacotherapies, the influence of genetics and hormones on responses to abused drugs and treatment medications, the pharmacological management of pain, and brain imaging studies of the neural correlates of drug effects.The journal will focus on clinical laboratory studies and controlled clinical medication trials as well as basic preclinical experiments on psychopharmacology and drug abuse.The journal also will include comprehensive and integrative reviews of advances in research on psychopharmacology. These reviews should provide a broad perspective on a particular area of research or trace the development of critical concepts and experimental approaches.Each year, the journal will recognize young investigators who are recipients of the Young Psychopharmacologist Award or the Best Dissertation Award, as well as midcareer and senior scientists who receive the Brady–Schuster Award from APA Division 28, Psychopharmacology and Substance Abuse. Awardees will be invited to submit a review paper based on their award-winning research.The journal may occasionally publish innovations in psychopharmacology that report a novel method, measure, or result. Commentary on the nature and implications of the innovation may be invited.The overall goal is to provide a forum for innovative clinical and preclinical research that advances our understanding of the behavioral and biological determinants of the effects of drugs.
Under new editorial leadership, Experimental and Molecular Pathology presents original articles on disease processes in relation to structural and biochemical alterations in mammalian tissues and fluids and on the application of newer techniques of molecular biology to problems of pathology in humans and other animals. The journal also publishes selected interpretive synthesis reviews by bench level investigators working at the "cutting edge" of contemporary research in pathology. In addition, special thematic issues present original research reports that unravel some of Nature's most jealously guarded secrets on the pathologic basis of disease.Research Areas include:• Stem cells• Neoangiogenesis• Molecular diagnostics• Polymerase chain reaction• In situ hybridization• DNA sequencing• Cell receptors• Carcinogenesis• Pathobiology of neoplasia• Complex infectious diseases• Transplantation• Cytokines• Flow cytomeric analysis• Inflammation• Cellular injury• Immunology and hypersensitivity• AthersclerosisBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com
Expert Opinion on Biological Therapy ranks #42 of 160 in the Biotechnology & Applied Microbiology category and #30 of 106 in the Medicine, Research & Experimental category in the 2009 ISI Journal Citation Reports.Expert Opinion on Biological Therapy (ISSN 1471-2598 [print], 1744-7682 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on all aspects of biological therapy, providing expert opinion on the scope for future development.The Editors welcome: * Reviews covering gene therapy and gene transfer technologies; therapeutic peptides and proteins; vaccines and antibodies; cell- and tissue-based therapies * Drug Evaluations reviewing the clinical data on a particular biological agent * Original research papers reporting the results of clinical investigations on biological agents and biotherapeutic-based studies with a strong link to clinical practiceThe audience consists of scientists and managers in the healthcare and biopharmaceutical industry and others closely involved in the development of biological therapy for the treatment of human disease.